Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System ("CNS") disorders, today announced financial results for the year ended December 31, 2023 and..... We are a clinical-stage biopharmaceutical company..
Relevance: 15.125506